Harpoon Therapeutics - Ownership and Business Overview

Life ScienceCompany

Harpoon Therapeutics Ownership

Who owns Harpoon Therapeutics?

Harpoon Therapeutics is owned by Merck. It was acquired on January 8, 2024.

Harpoon Therapeutics Business Overview

Where is Harpoon Therapeutics headquartered?

Harpoon Therapeutics is headquartered in South San Francisco, California.

What is Harpoon Therapeutics’ revenue?

Harpoon Therapeutics disclosed revenue of 32M USD for 2022 and 24M USD for 2021.

How many employees does Harpoon Therapeutics have?

Harpoon Therapeutics has 53 employees.

What sector is Harpoon Therapeutics in?

Harpoon Therapeutics is a life science company.

When was Harpoon Therapeutics founded?

Harpoon Therapeutics was founded in 2015.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 195 acquisitions of life science companies in 2024, including 17 acquisitions by private equity firms, and 178 by strategics.

Harpoon Therapeutics

Harpoon Therapeutics, Inc.

131 Oyster Point Boulevard, Suite 300,
South San Francisco, California 94080
United States,
(650) 443-7400
www.harpoontx.com

Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T-cell engagers designed to harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. Harpoon was founded in 2015 and is headquartered in South San Francisco, California.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.